Market Factors: Some very bad advice from a venture capitalist
There are few finance writers with better perspective than Collaborative Fund's Morgan Housel and he proved it again with the recent post called Very Bad Advice. Mr. Housel's goal is to underscore the complexity of success versus the simplicity of self-destruction.
The bulk of the piece is a very long list of beliefs that can undermine success in both investing and life. One example is 'Assume learning is complete upon your last day of school,' an obvious tongue-in-cheek warning to keep learning throughout life. There are a few points of bad advice that struck me as extremely important for investors.
The first is 'Forecast with precision, certainty, and confidence.' This is a reminder that any market-related predictions are just loose hypotheses and will almost certainly be wrong. All forecasts are to be held lightly and completely unrelated to an investor's ego. George Soros protégé Stan Druckenmiller once noted that Mr. Soros is the best trader alive because he knows when to abandon an investment thesis.
I am guilty of 'Believe that the past was golden, the present is crazy, and the future is destined for decline' to the point I'm considering buying defence stocks, which I describe as put options on human psychology. Things are crazier than usual where politics are concerned but investors should not fall victim to fatalism.
I also found 'View patience as laziness' as an important reminder for investors. Finance research shows conclusively that portfolio returns decline as the number of transactions increases. There are many times that the best thing to do in a portfolio is nothing.
'Adjust your willingness to believe something by how much you want and need it to be true' is another good one. I take this in a specific way that guards against a mistake I've made in the past, when I convinced myself an investment idea was great just because it was time to buy something.
Readers can judge for themselves but I find Mr. Housel one of the few finance writers who is truly wise and his bad advice in this column is helpful during market hours and beyond.
In what could be interpreted as a case of evil companies becoming even more evil, U.S. health insurers are implementing AI to streamline hospital operations and eventually cut jobs.
BofA Securities analyst Alec Stranahan reports that the U.S. health-care system is a jumble of administration for patients, insurers and hospitals that often requires manual input of data. The opportunity for efficiencies is widespread and some insurers and large hospital systems are already implementing AI applications to tackle them.
The stocks mentioned are new names for me. Doximity Inc. (DOCS-N), with AI applications to draft medical letters and appeals and communicate with patients, is one. Waystar Holding Inc (WAY-Q), with software to help simplify payment processing and claims denials, is another. Nashville-based hospital network HCA Holdings Inc. (HCA-N) is a leader in AI implementation in its own operations.
News that an unstable teen had been dragged into madness by an AI companion would be lamentable but not surprising. Futurism's description of venture capitalist Geoff Lewis' apparent AI-assisted descent into mental illness, however, is eyebrow raising.
Mr. Lewis was an investor in machine learning and AI expansion for a multi-billion dollar investment firm until a series of social media posts led to concerns about his health. The posts suggested that Mr. Lewis had used ChatGPT to uncover a shadowy organization that was negatively affecting 7,000 people and had killed more than ten people.
The story is the continuation of a trend of AI encouraging users' delusional thinking to extremes that are being blamed for involuntary stays at psychiatric facilities, homelessness and even suicide.
Mr. Lewis did not respond to requests for information for the story so we'll have to be careful in assuming AI's role in his difficulties. If it turns out that AI did play a significant role, it is alarming as Mr. Lewis has a clear idea of AI's inner workings.
Looking for our updates on market movers, analyst actions, stock technicals, insider trades and other daily, weekly and monthly insight? Click here to visit our Inside the Market page.
Norman Rothery hunts for the best measures of quality for both large and small Canadian stocks
Ian McGugan looks at the staggering amounts companies are spending on AI and what it may mean for investors. Meanwhile, Jamie McGeever asks, Is the U.S. stock rally near a 'Mag 7' turning point?
Tim Shufelt looks at how Canadians are learning the hard way that real estate is not a slam dunk when it comes to investment gains
The Bank of Canada decision on interest rates on Wednesday is the key economic event for the coming week despite economists expecting no change in the policy rate. Month-over-month GDP for May is out Thursday when economists expect a 0.1 per cent decline. On August 1st the S&P Global Canada manufacturing PMI for July is released.
There are lots of earnings so let's get right to it. On Tuesday we'll see George Weston Ltd. (C$3.352 per share expected) and Kinross Gold Corp. (US$0.318). On Wednesday there's CGI Inc. (C$2.083), Agnico Eagle Mines Ltd. (US$1.715), Canadian Pacific Kansas City Ltd. (C$1.13) and Toumaline Oil Corp. (C$1.031). On Thursday TC Energy Corp. (C$0.791), Cenovus Energy Inc. (C$0.157) and Cameco (C$0.469) report. Scheduled Friday are Fortis Inc. (C$0.702), Enbridge Inc. (C$0.579), Telus Corp. (C$0.232) and Suncor Energy (C$0.710).
In American economic news there's annualized GDP for the second quarter out on Wednesday (2.5 per cent expected) along with personal consumption. The Federal reserve decision on rates is the same day, no change is expected. On Thursday there's personal spending for June (a 0.4 per cent month-over-month rise is forecast), and the monthly change in the PCE price index (a rise of 0.3 per cent is expected).
The change in nonfarm payrolls is released Friday and 101,000 new jobs is expected. ISM manufacturing PMI is out the same day and economists predict a slightly contractionary 49.5 reading.
Widely followed corporate results start Tuesday with Procter & Gamble Co. ($1.422 per share expected), Corning Inc. ($0.572), Johnson Controls International ($1.021), Royal Caribbean Cruises Ltd. ($4.068), American Tower Corp. ($2.428) and Visa Inc. ($2.847). On Wednesday there's Ford Motor Co. ($0.328), Equinix Inc. ($6.742), Meta Platforms Inc. ($5.878) and Qualcomm ($2.711).
Thursday's profit reports include Mastercard ($4.022), Stryker Corp. ($3.071), Apple Inc. ($1.43) and Amazon.com ($1.323). On August fourth we gat Berkshire Hathaway Inc. ($7514.74) and Palantir Technologies Inc ($0.139).
See our full earnings and economic calendar here
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
an hour ago
- Globe and Mail
The Cheesecake Factory Named to the ‘People Companies That Care' List for Fifth Consecutive Year
The Cheesecake Factory Incorporated (NASDAQ: CAKE) has been recognized as one of the 2025 PEOPLE Companies That Care ®, according to PEOPLE magazine and Great Place to Work ®. The Cheesecake Factory ® ranked 46 on the list, which is determined in large part by a confidential employee survey that measures the organization's culture and impact on its community and the planet. This press release features multimedia. View the full release here: Earning a spot on the list means that The Cheesecake Factory has surpassed rigorous benchmarks, establishing itself as one of the best companies to work for in the country. 'The Cheesecake Factory is honored to be named to the PEOPLE Companies that Care list for the fifth year in a row,' said David Overton, Founder, Chairman and CEO of The Cheesecake Factory Incorporated. 'For more than forty-five years we have strived to create a very special company culture of doing the right thing and giving back to the communities we serve, and this award is such a wonderful acknowledgment of what we continue to work to create.' Among The Cheesecake Factory's signature programs that support its local communities is the Nourish Program whereby the company regularly donates excess food from its restaurants to local non-profits. Through this program the company donated more than 820,000 pounds of food to more than 600 local non-profits in 2024. In addition to helping combat hunger, the company's Nourish Program donations also help reduce greenhouse gas emissions and send less materials to landfills. And, through the sale of its specially designated cheesecakes, since 2008 The Cheesecake Factory has donated more than $6.8 million to Feeding America ®, the largest hunger-relief organization in the United States, with a nationwide network of partner food banks, agencies, food pantries and meal programs helping to provide billions of meals to people facing hunger. Additionally, through the Give Back program, sponsored by The Cheesecake Factory Oscar and Evelyn Overton Charitable Foundation, the company's staff members can volunteer their time for fundraising and community service projects for the charities of their choice, contributing thousands of volunteer hours to hundreds of charities across the country every year. In 2025, The Cheesecake Factory was named one of the Fortune "100 Best Companies to Work For ®" for the twelfth consecutive year. For more information about The Cheesecake Factory, visit For career opportunities, visit About The Cheesecake Factory Incorporated The Cheesecake Factory is a leader in experiential dining. We are culinary forward and relentlessly focused on hospitality. Delicious, memorable experiences created by passionate people – this defines who we are and where we are going. We currently own and operate 363 restaurants throughout the United States and Canada under brands including The Cheesecake Factory ®, North Italia ®, Flower Child ® and a collection of other FRC brands. Internationally, 34 The Cheesecake Factory ® restaurants operate under licensing agreements. Our bakery division operates two facilities that produce quality cheesecakes and other baked products for our restaurants, international licensees and third-party bakery customers. In 2025, we were named to the FORTUNE Magazine "100 Best Companies to Work For ®" list for the twelfth consecutive year. To learn more, visit and From Fortune. ©2025 Fortune Media IP Limited. All rights reserved. Used under license. Fortune ® and Fortune 100 Best Companies to Work For ® are registered trademarks of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, The Cheesecake Factory Incorporated. About the PEOPLE Companies that Care List Great Place To Work selected the 2025 PEOPLE Companies that Care List by gathering and analyzing over 1.3 million confidential survey responses from companies representing more than 8.4 million U.S. employees at Great Place To Work Certified organizations. Of those, more than 1 million responses came from employees at companies eligible for the list and these rankings are based on that feedback. Company rankings are derived from 60 employee experience questions within the Great Place To Work Trust Index™ Survey and essays submitted by participating companies. Read the full methodology. About Great Place to Work ® As the global authority on workplace culture, Great Place To Work brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and Great Place To Work Model™ help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified or receiving recognition on a coveted Best Workplaces™ List. Visit to learn more.


Globe and Mail
an hour ago
- Globe and Mail
Lost Money on Hims & Hers Health, Inc. (HIMS)? Contact Levi & Korsinsky to Join Class Action Before August 25, 2025
New York, New York--(Newsfile Corp. - August 20, 2025) - If you suffered a loss on your Hims & Hers Health, Inc. (NYSE: HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. Cannot view this video? Visit: THE LAWSUIT: A class action securities lawsuit was filed against Hims & Hers Health, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between April 29, 2025 and June 23, 2025. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Hims was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;" (2) as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Hims & Hers Health, Inc. stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes. To view the source version of this press release, please visit


Globe and Mail
an hour ago
- Globe and Mail
Inventronics Announces 2025 Q2 Financial Results
CALGARY, Alberta, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inventronics Limited (the 'Corporation') (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and the USA, today announced its unaudited 2025 Q2 financial results. For the three months ended June 30, 2025, Inventronics reported net earnings of $138,000, or 2.8 cents per share, on revenue of $2,190,000 compared to net earnings of $141,000, or 2.9 cents per share, on revenue of $1,950,000 for the three months ended June 30, 2024. For the six months ended June 30, 2025, Inventronics reported net earnings of $321,000, or 6.6 cents per share, on revenue of $4,617,000 compared to net earnings of $149,000, or 3.1 cents per share, on revenue of $3,394,000 for the comparative period in 2024. Financial Highlights Three months ended Six months ended (in thousands of dollars, except per share amounts) Jun 30 2025 Jun 30 2024 Jun 30 2025 Jun 30 2024 Revenue 2,190 1,950 4,617 3,394 Net earnings 138 141 321 149 Basic earnings per share 2.8¢ 2.9¢ 6.6¢ 3.1¢ Financial Position As at (in thousands of dollars) Jun 30 2025 Dec 31 2024 Working capital 1,815 1,536 Property, plant and equipment 3,178 3,244 Long-term debt, excluding current portion 2,151 2,250 Shareholders' equity 2,592 2,267 Further information about the financial results of the Corporation can be found in the Corporation's unaudited interim financial statements for the quarter ended June 30, 2025 and accompanying management's discussion and analysis ("2025 Q2 MD&A") filed on SEDAR+ at About Inventronics Inventronics Limited designs and manufactures enclosures and other products for an array of customers in the telecommunications, cable, electric distribution, energy, and other industries in Canada and the USA. The Corporation owns its ISO 9001-registered production facility in Brandon, Manitoba. Shares of Inventronics trade on the TSX Venture Exchange under the symbol 'IVX.' For more information about the Corporation, its products and its services, go to